Evidence map›Paper›PMID 31373418›Full record

Trial reportJournal of clinical laboratory analysis2019

Remifentanil inhibits the traumatic stress response in emergent trauma surgery.

Ru Ouyang, Haijing Ren, Wei Liu, Xi Yuan, Enjun Lei

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of clinical laboratory analysis, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Observational
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ru OuyangDepartment of Anesthesiology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Haijing RenDepartment of Medicine, Graduate School, Nanchang University, Nanchang, China.
Wei LiuDepartment of Anesthesiology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Xi YuanDepartment of Medicine, Graduate School, Nanchang University, Nanchang, China.
Enjun LeiDepartment of Anesthesiology, The First Affiliated Hospital of Nanchang University, Nanchang, China.ORCID https://orcid.org/0000-0003-2877-7199
Nanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this study was to explore whether remifentanil could inhibit the stress response in emergent trauma surgery more effectively than sufentanil. PATIENTS AND

methodsSixty trauma patients for emergent surgery were randomly divided into remifentanil group (R group, n = 30) or sufentanil group (S group, n = 30). The patients in the R group were continuously intravenously infused with remifentanil, while those in the S group were administrated with sufentanil. The plasma contents of cortisol (COR), epinephrine (E), norepinephrine (NE), and blood glucose were measured before anesthesia induction (T1), 5 minutes after intratracheal intubation (T2) and 5 minutes (T3), 30 minutes (T4), and 1 hour (T5) after surgery, respectively. The blood pressure (BP) and the heart rate (HR) at these time points were recorded as well.

resultsThe results showed that the patients in the R group had more stable hemodynamics during the surgery and had a significantly lower HR at T2-T5 than those in the S group. The plasma levels of norepinephrine at time points T3-T5 and levels of cortisol at T4-T5 in the R group were significantly lower than those in the S group (P < 0.05).

conclusionsThe results in the present study indicated that remifentanil could inhibit the stress response in emergent trauma surgery patients more effectively than sufentanil.

Indexed as

AdolescentAdultAgedAnalgesics, OpioidBiomarkersEmergency Service, HospitalEpinephrineFemaleFollow-Up StudiesHumansMaleMiddle AgedPostoperative ComplicationsPrognosisRemifentanilStress, PhysiologicalAnalgesics, OpioidBiomarkersEpinephrineRemifentanilSufentanilemergent surgery protectionremifentanilstress responsesufentaniltrauma

Identifiers

PMID31373418
PMCPMC6805290
OpenAlexW2964491969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.